Latest DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Stock Portfolio

$5.75Billion– No. of Holdings #361

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Performance:

2024 Q1: 13.26%YTD: 13.26%2023: 24.35%

Performance for 2024 Q1 is 13.26%, and YTD is 13.26%, and 2023 is 24.35%.

About DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) and 13F Hedge Fund Stock Holdings

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) is a hedge fund based in NEW YORK, NY. On 31-May-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $15.1 Billions. In it's latest 13F Holdings report, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) reported an equity portfolio of $5.7 Billions as of 31 Mar, 2024.

The top stock holdings of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) are NUVL, VTRS, CNC. The fund has invested 26.1% of it's portfolio in NUVALENT INC and 4.4% of portfolio in VIATRIS INC.

The fund managers got completely rid off RAYZEBIO INC, CAREMAX INC (CMAX) and TRIMAS CORP (TRS) stocks. They significantly reduced their stock positions in BAXTER INTL INC (BAX), VIKING THERAPEUTICS INC (VKTX) and WOODWARD INC (WWD). DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) opened new stock positions in BIONTECH SE (BNTX), KYVERNA THERAPEUTICS INC and SOLID BIOSCIENCES INC (SLDB). The fund showed a lot of confidence in some stocks as they added substantially to CONMED CORP (CNMD), CAREMAX INC (CMAX) and AMPLIFY ENERGY CORP NEW (AMPY).

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Equity Portfolio Value

Last Reported on: 15 May, 2024

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Annual Return Estimates Vs S&P 500

Our best estimate is that DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) made a return of 13.26% in the last quarter. In trailing 12 months, it's portfolio return was 58.3%.

New Buys

Ticker	$ Bought
integra lifesciences hldgs c	98,735,500
biontech se	52,543,200
kyverna therapeutics inc	36,324,500
perspective therapeutics inc	33,531,400
solid biosciences inc	30,108,500
lantheus hldgs inc	28,020,900
inmode ltd	25,212,500
accolade inc	24,964,400

New stocks bought by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

Additions

Ticker	% Inc.
conmed corp	13,130
caremax inc	2,900
amplify energy corp new	468
gopro inc	413
the beauty health company	321
n-able inc	315
angiodynamics inc	203
blue owl capital corporation	202

Additions to existing portfolio by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

Reductions

Ticker	% Reduced
baxter intl inc	-99.55
viking therapeutics inc	-63.76
woodward inc	-59.47
motorola solutions inc	-56.16
replimune group inc	-55.68
ramaco res inc	-54.77
maximus inc	-53.53
springworks therapeutics inc	-50.35

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) reduced stake in above stock

Sold off

Ticker	$ Sold
glaukos corp	-414,909,000
invitae corp	-186,987,000
natera inc	-172,440,000
rayzebio inc	-62,550,900
caremax inc	-7,908,040
nyxoah s a	-811,267
somalogic inc	-14,400
lexicon pharmaceuticals inc	-157,810

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) got rid off the above stocks

Sector Distribution

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) has about 88.6% of it's holdings in Healthcare sector.

Sector	%
Healthcare	88.6
Others	7.7
	2.3

Market Cap. Distribution

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) has about 11.2% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
MID-CAP	47.3
SMALL-CAP	32.1
LARGE-CAP	11.2
UNALLOCATED	7.7
MICRO-CAP	1.3

Stocks belong to which Index?

About 0% of the stocks held by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) either belong to S&P 500 or RUSSELL 2000 index.

Index	%
Others	100

Top 5 Winners (%)		%
NUVB	nuvation bio inc	404.2 %
SMFR	genedx holdings corp	232.0 %
VKTX	viking therapeutics inc	183.7 %
VTYX	ventyx biosciences inc	122.7 %
FUSN	fusion pharmaceuticals inc	121.8 %

Top 5 Winners ($)		$
FUSN	fusion pharmaceuticals inc	75.0 M
OSCR	oscar health inc	62.4 M
AHCO	adapthealth corp	56.0 M
MRUS	merus n v	52.5 M
SBTX	ars pharmaceuticals inc	52.5 M

Top 5 Losers (%)		%
WW	ww intl inc	-50.8 %
CMAX	caremax inc	-49.5 %
CMAX	caremax inc	-37.3 %
QDEL	quidelortho corp	-35.0 %
ALHC	alignment healthcare inc	-32.8 %

Top 5 Losers ($)		$
ALHC	alignment healthcare inc	-20.0 M
IART	integra lifesciences hldgs c	-10.8 M
EMBC	embecta corp	-9.9 M
QDEL	quidelortho corp	-9.0 M
DCGO	docgo inc	-8.3 M

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) has 361 stocks in it's portfolio. About 51% of the portfolio is in top 10 stocks. ALHC proved to be the most loss making stock for the portfolio. FUSN was the most profitable stock for DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) last quarter.

Last Reported on: 15 May, 2024

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
AAPL	apple inc	0.01	3,449	591,435	new

ABSI	absci corporation	0.00	47,441	269,465	new

ACAD	acadia pharmaceuticals inc	0.00	0.00	0.00	sold off	-100

ACCD	accolade inc	2.04	132,598,000	117,482,000	unchanged	0.00

ACCD	accolade inc	0.43	2,382,100	24,964,400	new

ACLS	axcelis technologies inc	0.01	5,969	665,663	new

ADBE	adobe inc	0.01	1,024	516,710	new

ADM	archer daniels midland co	0.00	0.00	0.00	sold off	-100

ADMA	adma biologics inc	0.01	81,204	535,946	added	90.37

ADPT	adaptive biotechnologies cor	0.00	65,287	209,571	new

AEO	american eagle outfitters in	0.00	11,856	305,766	added	0.36

AFIB	acutus med inc	0.01	2,660,810	500,232	unchanged	0.00

AGIO	agios pharmaceuticals inc	0.01	17,658	516,320	new

AGL	agilon health inc	0.01	68,033	415,001	new

AGYS	agilysys inc	0.01	7,999	673,996	new

AHCO	adapthealth corp	2.65	13,257,900	152,599,000	reduced	-2.57

AIN	albany intl corp	0.00	3,224	301,476	new

AKBA	akebia therapeutics inc	0.00	47,100	86,193	new

AKRO	akero therapeutics inc	0.01	13,645	344,673	new

ALEC	alector inc	0.11	1,072,840	6,458,530	added	0.47